LncRNA DGUOK-AS1 Promotes Bladder Cancer Progression by Enhancing EFTUD2 Stability
DGUOK-AS1 drives BC progression via the EFTUD2/MST1R/Akt axis, offering a promising therapeutic target for BC treatment.
Authors
- Wenwei Ying
- Dingliang Li
- Ninghan Feng (ORCID: https://orcid.org/0000-0002-0892-6102)
- Wei Wei (ORCID: https://orcid.org/0000-0002-0663-6275)
Institutions
- Peking University (CN)
- Wuxi No.2 People's Hospital (CN)
- Peking University First Hospital (CN)
- Hunan New Wellful (China) (CN)
- Wuxi People's Hospital (CN)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2025-09-18
- DOI
- https://doi.org/10.4143/crt.2025.468
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peking University First Hospital
- Peking University